Renaissance Technologies’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-283,700
| Closed | -$19.3M | – | 4584 |
|
|
2022
Q3 | $19.3M | Buy |
+283,700
| New | +$19.3M | 0.03% | 691 |
|
|
2022
Q1 | – | Sell |
-8,935
| Closed | -$262K | – | 4614 |
|
|
2021
Q4 | $262K | Sell |
8,935
-76,426
| -90% | -$2.24M | ﹤0.01% | 3404 |
|
|
2021
Q3 | $2.18M | Buy |
85,361
+34,681
| +68% | +$884K | ﹤0.01% | 2026 |
|
|
2021
Q2 | $1.78M | Buy |
+50,680
| New | +$1.78M | ﹤0.01% | 2335 |
|
|
2020
Q3 | – | Sell |
-50,400
| Closed | -$3.18M | – | 3799 |
|
|
2020
Q2 | $3.18M | Buy |
50,400
+42,300
| +522% | +$2.67M | ﹤0.01% | 1905 |
|
|
2020
Q1 | $414K | Buy |
+8,100
| New | +$414K | ﹤0.01% | 2850 |
|
|
2018
Q3 | – | Sell |
-217,700
| Closed | -$9.84M | – | 3637 |
|
|
2018
Q2 | $9.84M | Sell |
217,700
-394,100
| -64% | -$17.8M | 0.01% | 1362 |
|
|
2018
Q1 | $29.6M | Buy |
+611,800
| New | +$29.6M | 0.03% | 707 |
|
|
2017
Q4 | – | Sell |
-186,400
| Closed | -$5.79M | – | 3555 |
|
|
2017
Q3 | $5.79M | Buy |
+186,400
| New | +$5.79M | 0.01% | 1679 |
|
|
2016
Q4 | – | Sell |
-101,200
| Closed | -$2.33M | – | 3540 |
|
|
2016
Q3 | $2.33M | Buy |
+101,200
| New | +$2.33M | ﹤0.01% | 2097 |
|